In a strategic move, Puig, a global luxury and beauty leader, secures a majority stake in the cutting-edge German molecular cosmetics brand, Dr. Barbara Sturm. While the founder retains a minority stake, Dr. Sturm will continue as Chief Product Development Officer and brand ambassador, driving innovation.
Founded in 2014, Dr. Barbara Sturm is acclaimed for its scientific approach to skincare, offering a diverse range of products, including skincare, body care, hair care, and supplements. This acquisition reinforces Puig’s commitment to dominating the premium skincare sector.
The collaboration leverages Dr. Barbara Sturm’s global recognition, digital prowess, and an extensive network of spas and boutiques. Puig anticipates this strategic addition to boost international expansion, with plans for growth in key locations such as Düsseldorf, London, New York, and more.
Puig’s CEO, Marc Puig, emphasizes the brand’s scientific approach, stating, «Dr. Barbara Sturm’s effective treatments reinforce our position in the premium skincare segment.»
Dr. Barbara Sturm highlights the shared entrepreneurial spirit, aiming to introduce their skincare products to a broader audience through this partnership.
This collaboration is set to elevate Dr. Barbara Sturm’s global presence, offering a product line free from synthetic fragrances, harsh preservatives, or parabens. With a commitment to cruelty-free practices and suitability for all skin types, the brand’s appeal is poised for expansion.
Known for pioneering anti-inflammatory treatments, Dr. Sturm’s innovative products include the ‘Blood Facial’ and personalized plasma-based moisturizer MC1. The brand currently operates seven spas and boutiques, symbolizing its dedication to innovation and quality.
